Valued at a market cap of $30.1 billion, DTE Energy Company (DTE) is a diversified regulated utility holding company headquartered in Detroit, Michigan. It primarily provides electricity and natural gas to customers in Michigan through its two regulated subsidiaries, DTE Electric and DTE Gas, while also operating a portfolio of non-utility energy businesses. Shares of this utility company have outpaced the broader market over the past 52 weeks. DTE has surged 13.4% over this time frame, while the broader ...

Founded in 1932, Melville, New York-based Henry Schein, Inc. (HSIC) provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. The company has a market capitalization of $9.2 billion and operates through Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology segments. The company's shares have underperformed the broader market over the past year but have slightly outperformed in 2026. HSIC sto ...

Core Viewpoint - Wall Street analysts anticipate a decline in Macerich's quarterly earnings per share, projecting $0.43, which reflects an 8.5% year-over-year decrease, while revenues are expected to increase by 3.5% to $283.31 million [1] Earnings Estimates - There has been a downward revision of 3.1% in the consensus EPS estimate over the last 30 days, indicating a reassessment by analysts of their initial forecasts [1][2] Revenue Projections - Analysts predict 'Leasing Revenue- Minimum rents' will reach $167.66 million, showing a year-over-year increase of 5.4% [4] - 'Management Companies revenues' are expected to decline to $6.09 million, reflecting a 21.1% decrease from the previous year [4] - 'Leasing Revenue- Tenant recoveries' is forecasted at $71.99 million, indicating a year-over-year increase of 9.3% [4] - 'Leasing Revenue- Percentage rents' is estimated to be $18.92 million, suggesting a 16.2% year-over-year decline [5] - 'Depreciation and amortization' is expected to be $92.30 million [5] Stock Performance - Over the past month, Macerich shares have returned -1.2%, compared to the Zacks S&P 500 composite's -1.7% change, indicating a slight outperformance relative to the index [5] - With a Zacks Rank of 4 (Sell), Macerich is expected to underperform the overall market in the near term [5]

Company Overview - lululemon athletica inc. is based in Vancouver, Canada, and specializes in designing, distributing, and retailing technical athletic apparel, footwear, and accessories for both women and men under the lululemon brand. The company has a market capitalization of $20.7 billion [1]. Performance Analysis - Over the past 52 weeks, lululemon has significantly underperformed the broader market, with its shares declining by 54.9%, while the S&P 500 Index increased by 11.8%. Year-to-date, the stock is down 15.1%, contrasting with a slight drop in the S&P 500 [2]. - The company has also lagged behind the Amplify Online Retail ETF, which saw a decrease of 12.3% over the past 52 weeks and 13.9% year-to-date [3]. Recent Financial Results - On December 11, lululemon reported better-than-expected Q3 results, with shares surging by 9.6% in the following trading session. The company's total revenue rose by 7.1% year-over-year to $2.6 billion, exceeding Wall Street expectations by 3.6%. However, earnings per share (EPS) declined by 9.8% from the previous year to $2.59, although it surpassed analyst expectations of $2.22 [4]. Earnings Forecast - For the current fiscal year ending in January, analysts project lululemon's EPS to decline by 10.8% year-over-year to $13.06. The company has a strong earnings surprise history, having exceeded consensus estimates in each of the last four quarters [5]. Analyst Ratings - Among the 31 analysts covering lululemon, the consensus rating is a "Hold," which includes two "Strong Buy," 26 "Hold," one "Moderate Sell," and two "Strong Sell" ratings [5]. - The configuration of ratings has slightly shifted, with three analysts now suggesting a "Strong Buy" rating. JPMorgan Chase & Co. maintained a "Neutral" rating and raised its price target to $209, indicating an 18.5% potential upside from current levels [6]. - The mean price target of $210.58 represents a 19.4% premium to current price levels, while the highest price target of $320 suggests an ambitious 81.4% potential upside [7].

Marathon Petroleum Corporation (MPC), headquartered in Findlay, Ohio, functions as an integrated downstream energy company. Valued at $61.1 billion by market cap, the company refines, supplies, markets, and transports petroleum products. Shares of refining giant have outperformed the broader market over the past year. MPC has gained 31.9% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 11.8%. In 2026, MPC stock is up 25%, surpassing the SPX’s marginal fall on a YTD basis. ...

With a market cap of $62.3 billion, Air Products and Chemicals, Inc. (APD) is a global supplier of atmospheric, process, and specialty gases, serving a wide range of industries including energy, chemicals, manufacturing, electronics, food, and healthcare across the Americas, Asia, Europe, the Middle East, and India. It also designs and manufactures advanced equipment for air separation, hydrocarbon processing, natural gas liquefaction, and liquid hydrogen and helium storage and transport. Shares of the A ...

Core Insights - Protagonist Therapeutics, a clinical-stage biotech company, reported significant insider selling by director William D. Waddill, who sold 20,000 shares for approximately $1.7 million, despite the company's strong stock performance [1][2]. Company Overview - Protagonist Therapeutics focuses on peptide therapeutics to address unmet medical needs in hematology and immunology, particularly for patients with rare blood disorders and inflammatory diseases [5]. - As of February 14, 2026, the company's stock price was $81.49, with a market capitalization of $5.09 billion, revenue of $209.22 million, and net income of $45.91 million [4]. Transaction Details - The sale of 20,000 shares is five times larger than Waddill's recent median sell transaction of 4,000 shares, indicating a significant move [7]. - The transaction occurred when the stock was priced at $83.68, reflecting a 123.8% increase over the previous twelve months [7][8]. Market Context - Protagonist highlighted its projected growth at the J.P. Morgan Healthcare Conference, with two key pharmaceutical products in advanced clinical development, supported by major firms like Johnson & Johnson [8]. - Despite the insider selling, Wall Street analysts predominantly rate Protagonist's stock as a "strong buy," with a high price-to-earnings ratio of 113.15, suggesting strong growth expectations [6].

Core Insights - Rivian Automotive reported a revenue of $1.29 billion for the quarter ended December 2025, reflecting a year-over-year decline of 25.8% [1] - The company's EPS for the same period was -$0.54, slightly worse than the -$0.52 reported a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $1.26 billion, resulting in a surprise of +2.11% [1] - Rivian delivered an EPS surprise of +21.51%, compared to the consensus EPS estimate of -$0.69 [1] Performance Metrics - Rivian's delivery volume was 9,745 units, slightly below the four-analyst average estimate of 9,821 [4] - Revenue from software and services was $447 million, surpassing the average estimate of $397.28 million based on five analysts [4] - Automotive revenue was $839 million, which fell short of the average estimate of $861.1 million from five analysts [4] - Gross profit from software and services was $179 million, exceeding the average estimate of $149.21 million from three analysts [4] - Gross profit from automotive was -$59 million, better than the average estimate of -$145.74 million from three analysts [4] Stock Performance - Rivian Automotive shares have returned -15.7% over the past month, compared to a -0.3% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Applied Materials (AMAT) reported revenue of $7.01 billion for the quarter ended January 2026, reflecting a year-over-year decline of 2.2% and matching the EPS of $2.38 from the previous year [1] - The revenue exceeded the Zacks Consensus Estimate of $6.89 billion by 1.79%, while the EPS surpassed the consensus estimate of $2.19 by 8.53% [1] Financial Performance - The company’s shares have returned +12.6% over the past month, outperforming the Zacks S&P 500 composite, which saw a -0.3% change [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3] Geographic Net Sales - United States: $656 million, -28.5% year-over-year, below the estimate of $684.78 million [4] - Europe: $221 million, -33% year-over-year, below the estimate of $256.38 million [4] - Japan: $525 million, -2.8% year-over-year, slightly above the estimate of $518.68 million [4] - China: $2.1 billion, -6.6% year-over-year, above the estimate of $1.97 billion [4] - Taiwan: $1.72 billion, +45.6% year-over-year, below the estimate of $1.81 billion [4] - Southeast Asia: $335 million, +17.1% year-over-year, above the estimate of $271.34 million [4] - Korea: $1.46 billion, -12.5% year-over-year, above the estimate of $1.41 billion [4] Revenue Breakdown - Applied Global Services: $1.56 billion, matching the average estimate, -2.2% year-over-year [4] - Semiconductor Systems: $5.14 billion, above the average estimate of $4.97 billion, -4% year-over-year [4] - Corporate and Other: $312 million, above the estimate of $305.24 million, +845.5% year-over-year [4] Operating Income - Applied Global Services: $438 million, above the average estimate of $427.87 million [4] - Semiconductor Systems: $1.43 billion, below the average estimate of $1.81 billion [4]

Company Overview - PTC Inc. is based in Boston, Massachusetts, and provides global software solutions and services for manufacturing companies, focusing on product design, operation, and management [1] - The company has a market capitalization of $18.5 billion and offers a comprehensive portfolio that includes computer-aided design modeling and product lifecycle management [1] Stock Performance - Over the past 52 weeks, PTC shares have declined by 6.9%, while the S&P 500 Index has increased by 14.8% [2] - Year-to-date, PTC stock is down 11%, contrasting with a 1.5% gain in the S&P 500 [2] - PTC has also underperformed compared to the State Street Technology Select Sector SPDR ETF, which has risen by 20.9% in the same period [3] Recent Financial Results - Following the release of solid Q1 2026 results, PTC shares rose by 1.7% [6] - The company reported constant-currency Annual Recurring Revenue (ARR) growth of 8.4% to $2.5 billion and revenue of $686 million, marking a 21% year-over-year increase [6] - Adjusted EPS increased by 75% to $1.92, with an operating margin expansion to 32% and a 13% growth in both operating and free cash flow to approximately $270 million [6] Analyst Expectations - For the fiscal year ending in September 2026, analysts project a 3.6% year-over-year decline in EPS to $6.45 [7] - PTC has a strong earnings surprise history, having beaten consensus estimates in the last four quarters [7] - The consensus rating for PTC stock is "Moderate Buy," with 10 "Strong Buys," one "Moderate Buy," six "Holds," and one "Strong Sell" among 18 analysts [7] Price Target Insights - Citigroup analyst Tyler Radke maintained a "Neutral" rating for PTC and lowered the price target from $181 to $166 [8] - The mean price target of $197.18 suggests a premium of 26.7% over current levels, while the highest price target of $250 indicates a potential upside of 60.7% [8]